Blood Cancer Talks cover image

Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma

Blood Cancer Talks

00:00

The Role of Beer Cop in the Treatment of Solid Tumors

The next trial we came to hear your thoughts on is HD21 which is run by the German Hodgkin study group and that was a phase 3 trial of about 1500 patients where they could pet adapted breakad versus escalated beer cop. And depending on whether patients had a positive or negative interimpette scan they would either receive four cycles or six cycles of whichever arm they were randomized to. The three year PFS was 94.9% with breakad and 92.3% for escalated beer cop which demonstrated non inferiority and also showed a trend towards superiority. So yeah were there any other comments you wanted to add about 1826 before we swap to break hand? No I don't think so

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app